PortalPublikationenSecond-generation tyrosine kinase inhibitors in the post-tra...

Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.

Standard

Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia. / Klyuchnikov, Evgeny; Schafhausen, Philippe; Kröger, Nicolaus; Brümmendorf, Tim; Osanmaz, Okay; Asenova, Svetlana; Zabelina, Tatjana; Ocheni, Sunday; Ayuketang Ayuk, Francis; Zander, Axel R.; Bacher, Ulrike.

in: ACTA HAEMATOL-BASEL, Jahrgang 122, Nr. 1, 1, 2009, S. 6-10.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Klyuchnikov, E, Schafhausen, P, Kröger, N, Brümmendorf, T, Osanmaz, O, Asenova, S, Zabelina, T, Ocheni, S, Ayuketang Ayuk, F, Zander, AR & Bacher, U 2009, 'Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.', ACTA HAEMATOL-BASEL, Jg. 122, Nr. 1, 1, S. 6-10. <http://www.ncbi.nlm.nih.gov/pubmed/19602874?dopt=Citation>

APA

Klyuchnikov, E., Schafhausen, P., Kröger, N., Brümmendorf, T., Osanmaz, O., Asenova, S., Zabelina, T., Ocheni, S., Ayuketang Ayuk, F., Zander, A. R., & Bacher, U. (2009). Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia. ACTA HAEMATOL-BASEL, 122(1), 6-10. [1]. http://www.ncbi.nlm.nih.gov/pubmed/19602874?dopt=Citation

Vancouver

Klyuchnikov E, Schafhausen P, Kröger N, Brümmendorf T, Osanmaz O, Asenova S et al. Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia. ACTA HAEMATOL-BASEL. 2009;122(1):6-10. 1.

Bibtex

@article{93add227df7e4332afd66d7ffd844f13,
title = "Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.",
author = "Evgeny Klyuchnikov and Philippe Schafhausen and Nicolaus Kr{\"o}ger and Tim Br{\"u}mmendorf and Okay Osanmaz and Svetlana Asenova and Tatjana Zabelina and Sunday Ocheni and {Ayuketang Ayuk}, Francis and Zander, {Axel R.} and Ulrike Bacher",
year = "2009",
language = "Deutsch",
volume = "122",
pages = "6--10",
journal = "ACTA HAEMATOL-BASEL",
issn = "0001-5792",
publisher = "S. Karger AG",
number = "1",

}

RIS

TY - JOUR

T1 - Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.

AU - Klyuchnikov, Evgeny

AU - Schafhausen, Philippe

AU - Kröger, Nicolaus

AU - Brümmendorf, Tim

AU - Osanmaz, Okay

AU - Asenova, Svetlana

AU - Zabelina, Tatjana

AU - Ocheni, Sunday

AU - Ayuketang Ayuk, Francis

AU - Zander, Axel R.

AU - Bacher, Ulrike

PY - 2009

Y1 - 2009

M3 - SCORING: Zeitschriftenaufsatz

VL - 122

SP - 6

EP - 10

JO - ACTA HAEMATOL-BASEL

JF - ACTA HAEMATOL-BASEL

SN - 0001-5792

IS - 1

M1 - 1

ER -